STADLER, Rudolf et al. Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. Acta Oncologica, [S. l.], v. 45, n. 4, p. 389–399, 2006. DOI: 10.1080/02841860600630954. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/27459. Acesso em: 27 nov. 2024.